Serum antibody reactivity against recombinant PrtC of Porphyromonas gingivalis following periodontal therapy

被引:9
|
作者
Beikler, T
Ehmke, B
Wittstock, M
Schmidt, H
Karch, H
Flemmig, TF
机构
[1] Univ Munster, Dept Periodontol, D-4400 Munster, Germany
[2] Univ Wurzburg, Inst Infect Control & Microbiol, D-97070 Wurzburg, Germany
[3] Univ Munster, Inst Infect Control & Microbiol, D-4400 Munster, Germany
关键词
Porphyromonas gingivalis; protease; antibody; PrtC;
D O I
10.1034/j.1600-0765.2003.01405.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: In 34 patients with chronic periodontitis, the presence of IgA, IgG, and IgG subclass serum antibodies against recombinant PrtC (rPrtC) of Porphyromonas gingivalis was assessed by immunoblot analysis 24 months after therapy. Methods: rPrtC was produced from P. gingivalis ATTC 33277 using the plasmid pGEX-2T. In addition. intraoral colonization with P. gingivalis was detected by PCR in subgingival plaque and swab samples from buccal mucosae, tonsils and tongue at baseline. 10 d. and 3, 6, 9, 11 18, and 24 months. Results: All patients were found to harbor P. gingivalis in the oral cavity at least once during the observation period. The identified antibody responses against the rPrtC of P. gingivalis were IgA (970, i.e. 3334 patients) and IgG (100%, i.e. 34, 34). with an IgG subclass distribution of IgG2 (65%, r.e. 22/34 patients) > IgG3 (47%. i.e. 16 34) > IgG1 (38% i.e. 13 34) > IgG4 (29%,. i.e. 10 34). Anti-rPrtC IgA and IgG antibody reactivity was found in all but one patients (anti-rPrtC IgA negative). who tested negative for P. gingivalis at all of the assessed intraoral sites for at least 6 months before sera collection. There was no association between IgG subclass reactivity against the rPrtC of P. gingivalis and progression of periodontal attachment loss. Conclusion: The results indicated that anti-rPrtC IgA and IgG antibodies may serve as an indicator for past or present intraoral colonization with P. gingivalis.
引用
收藏
页码:276 / 281
页数:6
相关论文
共 50 条
  • [41] Differential involvement of the canonical and noncanonical inflammasomes in the immune response against infection by the periodontal bacteria Porphyromonas gingivalis and Fusobacterium nucleatum
    De Andrade, Kivia Queiroz
    Coutinho Almeida-da-Silva, Cassio Luiz
    Ojcius, David M.
    Coutinho-Silva, Robson
    CURRENT RESEARCH IN MICROBIAL SCIENCES, 2021, 2
  • [42] Antibacterial Activity of Cissus quadrangularis (Veldt Grape) Against Porphyromonas gingivalis, a Keystone Pathogen in Periodontal Disease: An In Vitro Study
    Nair, Aathira R.
    Rajula, Prem Blaisie
    Ravishankar, Pl
    Geddam, Sai Sri Soury
    Subhashini, B.
    Lochini, S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [43] Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence
    Rams, TE
    Listgarten, MA
    Slots, J
    JOURNAL OF PERIODONTAL RESEARCH, 2006, 41 (03) : 228 - 234
  • [44] The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice
    Gemmell, E
    Winning, TA
    Grieco, DA
    Bird, PS
    Seymour, GJ
    JOURNAL OF PERIODONTOLOGY, 2000, 71 (07) : 1130 - 1138
  • [45] Level of serum antibody against a periodontal pathogen is associated with atherosclerosis and hypertension
    Hanaoka, Yohsuke
    Soejima, Hirofumi
    Yasuda, Osamu
    Nakayama, Hideki
    Nagata, Masashi
    Matsuo, Katsuhiko
    Shinohara, Masanori
    Izumi, Yuichi
    Ogawa, Hisao
    HYPERTENSION RESEARCH, 2013, 36 (09) : 829 - 833
  • [46] Hyporesponsiveness of inflamed human gingival fibroblasts from patients with chronic periodontal diseases against cell surface components of Porphyromonas gingivalis
    Ogawa, T
    Ozaki, A
    Shimauchi, H
    Uchida, H
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1997, 18 (01): : 17 - 30
  • [47] Nano-Catechin Gel as a Sustained Release Antimicrobial Agent against Clinically Isolated Porphyromonas gingivalis for Promising Treatment of Periodontal Diseases
    Javadkhani, Anahita
    Shokouhi, Behnaz
    Mosayebzadeh, Amin
    Safa, Samira
    Fahimi, Mahsa
    Sharifi, Simin
    Dizaj, Solmaz Maleki
    Salatin, Sara
    BIOMEDICINES, 2023, 11 (07)
  • [48] Potential Value of a Rice Protein Extract, Containing Proteinaceous Inhibitors against Cysteine Proteinases from Porphyromonas gingivalis, for Managing Periodontal Diseases
    Taiyoji, Mayumi
    Yamanaka, Takashi
    Tsuno, Takuo
    Ohtsubo, Sadami
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2013, 77 (01) : 80 - 86
  • [49] The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats
    Hamada, Nobushiro
    Watanabe, Kiyoko
    Tahara, Tomoyuki
    Nakazawa, Kumiko
    Ishida, Isao
    Shibata, Yasuko
    Kobayashi, Tetsuo
    Yoshie, Hiromasa
    Abiko, Yoshimitsu
    Umemoto, Toshio
    JOURNAL OF PERIODONTOLOGY, 2007, 78 (05) : 933 - 939
  • [50] Vaccination with recombinant adhesins from the RgpA-Kgp proteinase-adhesin complex protects against Porphyromonas gingivalis infection
    Frazer, Leanne T.
    O'Brien-Simpson, Neil M.
    Slakeski, Nada
    Walsh, Katrina A.
    Veith, Paul D.
    Chen, Chao Guang
    Barr, Ian G.
    Reynolds, Eric C.
    VACCINE, 2006, 24 (42-43) : 6542 - 6554